1239320-01-4 Usage
Molecular structure
The compound has a spirocyclic core structure with an aminomethyl group at the 2-position and a 1,1-dimethylethyl ester group at the 6-position.
Biological activity
The compound has potential biological activity and is often used as a building block in the synthesis of various pharmaceuticals.
Stability
The 1,1-dimethylethyl ester group provides stability to the compound.
Pharmacokinetic properties
The 1,1-dimethylethyl ester group enhances the pharmacokinetic properties of the compound, making it a promising candidate for drug formulation and delivery.
Medicinal chemistry
The compound has potential pharmaceutical applications and is a valuable tool in drug discovery and development.
Research
Ongoing research is being conducted to further explore the potential of 2-(aminomethyl)-6-Azaspiro[3.4]octane-6-carboxylic acid 1,1-dimethylethyl ester in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1239320-01-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,9,3,2 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1239320-01:
(9*1)+(8*2)+(7*3)+(6*9)+(5*3)+(4*2)+(3*0)+(2*0)+(1*1)=124
124 % 10 = 4
So 1239320-01-4 is a valid CAS Registry Number.
1239320-01-4Relevant academic research and scientific papers
DERIVATIVES OF AZASPIRANYL-ALKYLCARBAMATES OF 5-MEMBER HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
-
, (2012/01/13)
The invention relates to a compound of the general formula (I) in which R2 is a hydrogen or fluorine atom or a hydroxyl, cyano, trifluoromethyl, C1-6-alkyl, C1-6-alkoxy, NR8R9 group; m, n, o and p are independently an integer equal to 0, 1, 2 or 3; A is a covalent bond or a C1-8-alkylene group; R1 is an optionally substituted aryl or heteroaryl group; R3 is a hydrogen or fluorine atom or a C1-6-alkyl group or a trifluoromethyl group; R4 is an optionally substituted 5-member heterocyclic compound; the compound being in the form of a base or acid addition salt. The invention also relates to the therapeutic use thereof.
